Axsome Therapeutics (AXSM) Assets (2015 - 2026)
Axsome Therapeutics' Assets was $761.45 million in Q2 2026, up 19.0% from $639.79 million a year earlier and up 6.7% from the prior quarter.
Powered by 
Analysis
Axsome Therapeutics (AXSM) Assets (2015 - 2026) Analysis & Trends
At the end of FY2025, Assets at Axsome Therapeutics came in at $689.81 million, up 21.3% from FY2024.
- Assets shows a five-year compound annual growth rate of 30.0% (FY2020 to FY2025).
- In earlier years, Assets was $568.5 million in FY2024 (-3.4%), $588.24 million in FY2023 (+77.5%), $331.48 million in FY2022 (+277.6%) and $87.79 million in FY2021 (-52.8%).
- The Q2 2026 figure marks the highest quarterly Assets in data going back to Q4 2015.
- Compared with a year earlier, Assets has increased for six straight quarters, with growth averaging 11.9% over the last eight quarters.
- The best year-over-year quarter for Assets over five years was Q1 2023 (growth of 339.5%); the worst was Q4 2021 (a decline of 52.8%).
- Per Business Quant data, AXSM's Assets in the three quarters before Q2 2026 was $713.61 million (Q1 2026), $689.81 million (Q4 2025) and $669.25 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Axsome Therapeutics | 10.14 Bn | 8.87 Bn | 204.81 Mn | 761.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 761.45 Mn |
| Mar 31, 2026 | 713.61 Mn |
| Dec 31, 2025 | 689.81 Mn |
| Sep 30, 2025 | 669.25 Mn |
| Jun 30, 2025 | 639.79 Mn |
| Mar 31, 2025 | 596.67 Mn |
| Dec 31, 2024 | 568.50 Mn |
| Sep 30, 2024 | 561.46 Mn |
| Jun 30, 2024 | 548.23 Mn |
| Mar 31, 2024 | 545.73 Mn |
| Dec 31, 2023 | 588.24 Mn |
| Sep 30, 2023 | 600.86 Mn |
| Jun 30, 2023 | 611.64 Mn |
| Mar 31, 2023 | 389.18 Mn |
| Dec 31, 2022 | 331.48 Mn |
| Sep 30, 2022 | 338.96 Mn |
| Jun 30, 2022 | 180.56 Mn |
| Mar 31, 2022 | 88.56 Mn |
| Dec 31, 2021 | 87.79 Mn |
| Sep 30, 2021 | 116.60 Mn |
API Access
Axsome Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=AXSM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "AXSM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=AXSM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();